2011
DOI: 10.1084/jem.20110750
|View full text |Cite
|
Sign up to set email alerts
|

Megakaryocytes possess a functional intrinsic apoptosis pathway that must be restrained to survive and produce platelets

Abstract: Deletion of Bak and Bax, the effectors of mitochondrial apoptosis, does not affect platelet production, however, loss of prosurvival Bcl-xL results in megakaryocyte apoptosis and failure of platelet shedding.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

17
206
0
2

Year Published

2012
2012
2019
2019

Publication Types

Select...
5
2

Relationship

2
5

Authors

Journals

citations
Cited by 163 publications
(225 citation statements)
references
References 76 publications
17
206
0
2
Order By: Relevance
“…Ploidy analysis revealed an increase in large polyploid megakaryocytes (32N, 64N) of the knockout mice ( Figure 1n) and their serum TPO levels were significantly lower than those of the control littermates ( Figure 1o); both findings were consistent with previous reports. 16 These findings suggested that Bcl-xL was involved in preventing mature megakaryocytes from apoptosis but was not essential for their growth and development.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Ploidy analysis revealed an increase in large polyploid megakaryocytes (32N, 64N) of the knockout mice ( Figure 1n) and their serum TPO levels were significantly lower than those of the control littermates ( Figure 1o); both findings were consistent with previous reports. 16 These findings suggested that Bcl-xL was involved in preventing mature megakaryocytes from apoptosis but was not essential for their growth and development.…”
Section: Resultsmentioning
confidence: 99%
“…Nevertheless, platelets possess Bcl-xL alone, unlike megakaryocytes in which two functional anti-apoptotic proteins, Bcl-xL and Mcl-1, are present. 11,12,16 We thus studied the effect of post-transcriptional degradation of Mcl-1 in platelets in vivo. At 1 or 2 days after the administration to wild-type mice of MG-132, a proteasome inhibitor, western blot revealed that the Mcl-1 protein was observed in platelets isolated from the MG-132-treated mice in contrast to platelets from the vehicle-treated mice (Figure 6a).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…In platelets, BCL-X L is the primary prosurvival protein that restrains BAK and BAX [18][19][20][21] . Accordingly, mutations in murine BCL-X L cause dose-dependent, cell-intrinsic reductions in platelet lifespan 18,19,22 . Moreover, pharmacological blockade of BCL-X L with the BH3 mimetic drugs ABT-737 (ref.…”
mentioning
confidence: 99%
“…In megakaryocytes, MCL-1 and BCL-X L are both required to keep BAK and BAX in check 18,28,29 . Their simultaneous deletion leads to a failure of megakaryopoiesis, haemorrhage and embryonic lethality.…”
mentioning
confidence: 99%